Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-02-25 @ 8:17 PM
Study NCT ID:
NCT03242603
Status:
UNKNOWN
Last Update Posted:
2018-03-30
First Post:
2017-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells
Sponsor:
National University Hospital, Singapore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NKEXPGD2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None